Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/44A
Name: Drug, bio-affecting and body treating compositions >
Description:










Sub-classes under this class:

Class Number Class Name Patents
514/ Dermatitis 0
514/ Mouth treatment 0
514/ Liquid carrier, diluent or solvent 0
514/ Solid carrier or solid diluent 0
514/ Gaseous or gas emitting carrier or propellant 0
514/ Pill, lozenge, tablet or capsule 0
514/ Suppository, bougie or base 0
514/ Special designated ingredient 0
514/ Designated organic active ingredient containing (doai) 0
514/1 Designated organic active ingredient containing (doai) 691
514/769 Designated inorganic nonactive ingredient or elemental material other than water 191
514/772 Designated organic nonactive ingredient containing other than hydrocarbon 765
514/788.1 Solid synthetic organic polymer derived solely from hydrocarbon reactants as designated organic nonactive ingredient containing 33
514/789 Miscellaneous (e.g., hydrocarbons, etc.) 197
514/800 Lhrh like 204
514/801 Collagen, gelatin or derivatives thereof 217
514/802 Fibrinopeptides, blood-coagulation factors or derivatives 118
514/803 Kinin or derivatives 12
514/804 Phecmycin series or derivatives 5
514/805 Adrenocorticotropic hormone or derivatives 32
514/806 Somatostatin or derivatives 127
514/807 Oxytoxin, vasopressin or derivatives 62
514/808 Calcitonin or derivatives 63
514/809 Enkephalin or endorphin or derivatives 140
514/810 Addiction 103
514/814 Anemia 113
514/816 Anesthetic, general 110
514/817 Anesthetic, topical 147
514/818 Anesthetic, local 120
514/819 Antacid, oral 87
514/821 Antiarrhythmic 427
514/822 Anticoagulation 476
514/823 Antidote 89
514/824 Arteriosclerosis 630
514/825 Arthritis 719
514/826 Asthma 843
514/827 Astringent, nonfacial 24
514/829 Bite or sting 42
514/832 Blood substitute 179
514/833 Blood plasma extender 88
514/834 Coagulant 79
514/835 Caries 101
514/836 Chelate 231
514/837 Cholera 21
514/838 Cirrhosis 38
514/839 Contact lens treatment 126
514/841 Contraceptive 148
514/844 Cosmetic, facial 1,426
514/849 Cough and cold preparation 128
514/851 Cystic fibrosis 126
514/852 Dandruff 121
514/853 Decongestant 66
514/866 Diabetes 1,030
514/867 Diarrhea 206
514/868 Distemper 6
514/869 Diuretic 281
514/870 Edema 145
514/872 Emesis (motion sickness-nausea) 110
514/873 Emollient 260
514/874 Estrogenic agent (noncontraceptive) 70
514/875 Flea control 50
514/877 Gallstone 30
514/878 Geriatrics 65
514/880 Hair treatment (therapeutic-scalp) 469
514/882 Hemorrhoid preparation 68
514/883 Hodgkin's disease 29
514/884 Hypoglycemia 71
514/885 Immune response affecting drug 1,164
514/886 Inflammation, skin 545
514/888 Influenza 73
514/889 Interferon inducer 115
514/890 Irritant (e.g., tear gas, etc.) 7
514/891 Kidney stone 51
514/892 Laxative 93
514/893 Liver disorder 167
514/895 Malaria 94
514/896 Measles 11
514/898 Meningitis 14
514/899 Menstrual disorder 112
514/903 Multiple sclerosis 186
514/904 Multiple vitamins 131
514/906 Muscle relaxant 205
514/907 Muscular dystrophy 29
514/908 Leukemia 345
514/909 Obesity 334
514/912 Ophthalmic 1,056
514/916 Pyretic 138
514/917 Radioactive, anti- 35
514/918 Repellent 79
514/921 Shock 140
514/922 Side effect reduction by incorporation of a second designated ingredient 243
514/923 Sleep aid (insomnia) 96
514/924 Tuberculosis 50
514/925 Ulcer treatment 354
514/929 Vasodilator 426
514/930 Vasoconstrictor (nondecongestant) 60
514/931 Veneral disease 80
514/935 Uterine motility 41
514/936 Dmso containing 61
514/937 Dispersion or emulsion 1,385
514/944 Gel 1,196
514/945 Foam 230
514/946 Penetrant or absorbent (enhances penetration into subject treated) 399
514/948 Solid candy type 78
514/949 Naturally derived clay (e.g., bentonite, etc.) 75
514/950 Macromolecular (other than synthetic resins) 44
514/951 Powders, granules or particles of specified mesh or particle size 497
514/953 Shaped forms adapted for noningestible use other than suppository type (e.g., films, inserts, etc.) 171
514/957 Vapor emmitting composition 79
514/958 For smoking or inhaling 191
514/959 Breathing gases 53
514/960 Significant, tablet formulation (e.g., designated excipient, disintegrant, glydent or lubricant, etc.) 472
514/962 Capsule (e.g., gelatin, etc.) 314
514/964 Sustained or differential release type 328
514/966 Rectal 148
514/967 Vaginal 170
514/968 Urethral 42
514/969 Ointment or salve base 371
514/970 Containing designated ingredient to stabilize an active ingredient 516
514/974 Containing designated ingredient to reduce noxious effects of active ingredient (e.g., taste masking, odor reducing, etc.) 269
514/975 Characterized by the designated surfactant used 371


Patents under this class:

Patent Number Title Of Patent Date Issued
8710024 Treatment of influenza Apr. 29, 2014
8710020 Clusterin antisense therapy for treatment of cancer Apr. 29, 2014
8710021 Inhibition of HRP-3 using modified oligonucleotides Apr. 29, 2014
8710022 Cell proliferation inhibitor Apr. 29, 2014
8710023 Antisense modulation of C-reactive protein expression Apr. 29, 2014
8709483 System for targeted delivery of therapeutic agents Apr. 29, 2014
8703732 Composition for enhancing TRAIL sensitivity comprising inhibitors for expression or activity of TIP41 as a target gene of TRAIL sensitizer Apr. 22, 2014
8703735 Antisense antiviral compounds and methods for treating a filovirus infection Apr. 22, 2014
8703728 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini Apr. 22, 2014
8703731 Sphingosine-bound siRNA Apr. 22, 2014
8703730 Complement antagonists and uses thereof Apr. 22, 2014
8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene Apr. 22, 2014
8703128 Methods of modulating TGF.beta. signaling Apr. 22, 2014
8691786 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA Apr. 8, 2014
8691785 Compositions and methods for non-parenteral delivery of oligonucleotides Apr. 8, 2014
8691784 MCP-1 binding nucleic acids Apr. 8, 2014
8691783 MicroRNA-24 Apr. 8, 2014
8691782 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton Apr. 8, 2014
8691781 Compositions for treating respiratory viral infections and their use Apr. 8, 2014
8689459 Method and apparatus for spray drying and powder produced using said method Apr. 8, 2014
8691780 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby Apr. 8, 2014
8686052 Targeting agent for cancer cell or cancer-associated fibroblast Apr. 1, 2014
8685940 Impaired wound healing compositions and treatments Apr. 1, 2014
8685938 Methods to enhance T-cell mediated immune response Apr. 1, 2014
8685937 Nucleic acid aptamers Apr. 1, 2014
8680067 Targeting microRNAs for the treatment of liver cancer Mar. 25, 2014
8680065 Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and methods of use Mar. 25, 2014
8680063 RNA interference for the treatment of gain-of-function disorders Mar. 25, 2014
8680066 Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject Mar. 25, 2014
8679750 Methods and compositions for the treatment of Huntington'S disease Mar. 25, 2014
8673875 Method for treating atherosclerosis Mar. 18, 2014
8673874 Methods for treating pancreatic cancer Mar. 18, 2014
8673873 RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders Mar. 18, 2014
8673872 Method of modulation of expression of epidermal growth factor receptor(EGFR) involving miRNA Mar. 18, 2014
8673871 Compounds and methods for modulating expression ApoB Mar. 18, 2014
8673869 Determinants of sensitivity to chemotherapeutic agents Mar. 18, 2014
8669238 Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis Mar. 11, 2014
8669239 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells Mar. 11, 2014
8669236 Biotinylated compositions Mar. 11, 2014
8669102 Modulation of prion expression Mar. 11, 2014
8668898 Low radiocarbon dietary supplements and foods and methods of making and using same Mar. 11, 2014
8668933 Polyion complex of double-stranded ribonucleic acid Mar. 11, 2014
8664193 Compositions and methods for inhibiting expression of factor VII gene Mar. 4, 2014
8664192 Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer Mar. 4, 2014
8664191 Use of two microRNA moleculars in lung cancer prognosis and medicine preparation Mar. 4, 2014
8664190 Methods for treating hypercholesterolemia Mar. 4, 2014
8664189 RNA interference in skin indications Mar. 4, 2014
8664188 siRNA compositions and methods for potently inhibiting viral infection Mar. 4, 2014
8658615 Prohibitin as target for cancer therapy Feb. 25, 2014
8658614 Aptamer-containing compositions and methods for targeting E-selectin Feb. 25, 2014











 
 
  Recently Added Patents
Aperture stop
Systems, methods and apparatus for payment processing
Digital media content distribution
Wireless communication power control
Charged particle cancer therapy beam path control method and apparatus
Horizontal card holder
Method and apparatus for providing auto-completion of information
  Randomly Featured Patents
Subband coefficient prediction with pattern recognition techniques
Production of extreme purity aluminum
Fraud analysis in a contact database
Coupled MEMS structure for motion amplification
Purification method
Rotary switching valve
Print service, order acceptance method, and cooperation system and method
Method and device for producing three-dimensional molded parts and corresponding molded part
Adhesive composition
Aquatic vegetation shredder having bow and stern mounted high speed, large chopping propellers